Hiroshi Bando1,2,3*, Hiroko Ogawa3, Shinji Nagahiro3, Miwako Nakanishi3, Osami Watanabe3 1Medical Research/Tokushima University, Tokushima, Japan 2Japan Low Carbohydrate Diet Promotion Association (JLCDPA), Kyoto, Japan 3Yoshinogawa Hospital, Tokushima, Japan
Corresponding Author: Hiroshi BANDO, MD, PhD, FACP ORCID iD Address: Tokushima University /Medical Research, Nakashowa 1-61, Tokushima 770-0943, Japan. Received date: 16 April 2021; Accepted date: 30 April 2021; Published date: 08 June 2021
Citation: Bando H, Ogawa H, Nagahiro S, Nakanishi M, Watanabe O. Satisfactory Control for Glucose Profile by Combined Agents of Xultophy with A Small Dose. Diab Res Open Access. 2021 Jun 08;3(2):23-29.
Keywords: Xultophy, Insulin Degludec and Liraglutide, Humalog Mix 25, Type 2 Diabetes Mellitus, Bio-Psycho-Social
Abbreviations: IDeg/Lira: Insulin Degludec and Liraglutide; T2DM; Type 2 Diabetes Mellitus; LCD: Low Carbohydrate Diet; CR: Calorie Restriction
The patient was a 74-year-old female with type 2 diabetes mellitus (T2DM) treated on Humalog mix 25 twice a day. As social history, she has worked long years for growing and harvesting lotus roots. It gives physically heavy loading, which brings unstable glycemic daily control. She had to titrate minute regulation every time. For stable glucose variability, the treatment was changed to Xultophy, which is a specific combined agent of Insulin Degludec and Liraglutide (IDeg/Lira) once a day. Then, detailed glucose monitoring showed a better daily profile of blood glucose, irrespective of heavy or light work. It showed the bio-psycho-social benefit of Xultophy.